This study is testing a new diagnostic test called µCAN that takes a small sample of a patient's tumor and grows it in the lab. The test then screens many drugs to see which ones kill the cancer cells best. The goal is to help doctors choose the right treatment for each person wi…
Phase: NA • Sponsor: Oncosyne AS • Aim: Diagnosis
Last updated Jun 27, 2026 12:26 UTC